-
Sector Analysis
NewShort Bowel Syndrome (SBS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in SBS therapeutics. • There will be more than 94,000 diagnosed prevalent cases of SBS in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. • Glucagon-like peptide 2 receptor agonists play a key role in the current treatment paradigm for SBS. • R&D activity in SBS is promising with three drugs in Phase III development. • The clinical trials space in SBS includes both commercial...
-
Product Insights
NewInflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Inflammatory Bowel Disease Clinical Trials Market Report Overview The Inflammatory Bowel Disease clinical trial market research report provides an overview of Inflammatory Bowel Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Bowel Disease. The report also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Thematic Analysis
Digital Marketing Trends in Inflammatory Bowel Disease
Digital Marketing Trends in Inflammatory Bowel Disease Report Overview AbbVie’s Skyrizi.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, with over 9.3 million visitors from March 2022 to February 2023. This was followed by AbbVie’s Rinvoq.com and Takeda’s Entyvio.com. The highest proportion of traffic originated from direct sources, followed by organic. Xeljanz.com was supported by the most paid search engine optimization (SEO) while Takeda spent on digital display advertising (DDA) for Entyvio.com. The digital marketing...
-
Sector Analysis
Ulcerative Colitis (UC) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031
Ulcerative Colitis Market Report Overview The ulcerative colitis (UC) market size across the 8MM was valued at $7.3 billion in 2021 and is expected to achieve a CAGR of more than 2% during 2021-2031. The symptoms of UC vary from person to person and may include diarrhea with blood or pus, passing blood with stool, abdominal pain & cramping, and tenesmus or urgency to defecate. UC can occur at any age, although most people are diagnosed in their mid-thirties. Men...
-
Product Insights
Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Zollinger-Ellison Syndrome Clinical Trials Market Report Overview The Zollinger-Ellison Syndrome clinical trial market research report provides an overview of the Zollinger-Ellison Syndrome clinical trials scenario. The report provides top-line data relating to the clinical trials on Zollinger-Ellison Syndrome. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Market Report Overview The Non-Alcoholic Steatohepatitis (NASH) clinical trial market research report provides an overview of the NASH clinical trials scenario. The report provides top-line data relating to the clinical trials on NASH. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031
Ulcerative Colitis Market Report Overview In the 8MM, there were 1,946,428 diagnosed prevalent cases of Ulcerative Colitis (UC) in 2021. The cases are expected to achieve an AGR of less than 1% during the period 2021-2031. Of the 8MM, Canada is expected to have the highest increase in the number of diagnosed prevalent cases of UC by 2031, and Italy will have the lowest increase in the number of diagnosed prevalent cases. Any change in the diagnosed prevalent cases of...
-
Product Insights
Gastric Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Gastric Ulcers Clinical Trials Market Report Overview The Gastric Ulcers clinical trial market research report provides an overview of the Gastric Ulcers clinical trials scenario. The report provides top-line data relating to the clinical trials on Gastric Ulcers. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
NAFLD Clinical Trials Market Report Overview The NAFLD clinical trial market research report provides an overview of the NAFLD clinical trials scenario. The report provides top-line data relating to the clinical trials on NAFLD. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Liver Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Liver Fibrosis Clinical Trials Market Report Overview The liver fibrosis clinical trial market research report provides an overview of the liver fibrosis clinical trial scenario. The report provides top-line data relating to the clinical trials on liver fibrosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Non-Alcoholic Fatty Liver Disease (NAFLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Non Alcoholic Fatty Liver Pipeline Drugs Analysis Overview Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease characterized by hepatic steatosis when no other causes for secondary hepatic fat accumulation (such as excessive alcohol consumption) can be identified. NAFLD ranges from the more benign condition of non-alcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), which is at the more severe end of the spectrum. The NAFLD marketed and pipeline drugs market research report provides a data-driven overview of the...
-
Product Insights
Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, a tendency to bruise or bleed easily, ascites, impaired brain function (encephalopathy), poor weight gain and growth, fatigue, weakness, nausea, and loss of appetite. Since these symptoms are associated with a host of other conditions, it may take some time before the correct diagnosis is made. As liver failure...
-
Product Insights
Short Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine. Symptoms include bloating, cramping, fatigue, heartburn, vomiting, weakness, and diarrhea. Complications of short bowel syndrome include malnutrition, peptic ulcers, kidney stones, and small intestinal bacterial overgrowth. Treatment includes vitamin and mineral supplements, antibiotics, proton pump inhibitors, and bile-salt binders The Short Bowel Syndrome pipeline drugs market research report provides comprehensive information on...
-
Product Insights
Peptic Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peptic Ulcers are open sores that develop on the inside lining of the esophagus, stomach, and the upper portion of the small intestine. Symptoms include nausea or vomiting, unexplained weight loss, appetite changes, and abdominal pain. Risk factors include smoking and alcoholism. Treatment includes antibiotics, acid blockers, antacids, and proton pump inhibitors. The Peptic Ulcers pipeline drugs market research report provides comprehensive information on the therapeutics under development for Peptic Ulcers, complete with analysis by stage of development, drug target,...
-
Product Insights
Gastroenteritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The gastroenteritis clinical trial market research report provides an overview of the gastroenteritis clinical trials scenario. The report provides top-line data relating to the clinical trials on gastroenteritis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Liver Failure (Hepatic Insufficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Liver Failure clinical trial market research report provides an overview of the Liver Failure (Hepatic Insufficiency) clinical trials scenario and top-line data relating to the clinical trials on Liver Failure (Hepatic Insufficiency). It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape
Autoimmune Hepatitis Marketed and Pipeline Drugs Report Overview Autoimmune Hepatitis (AIH) is four times more common in females than in males and is commonly associated with other autoimmune conditions, including type one diabetes, Hashimoto’s thyroiditis, and celiac disease. The persistent inflammation within the liver observed in AIH can result in scarring, ultimately leading to cirrhosis, liver failure (requiring a liver transplant), and even death. The Autoimmune Hepatitis marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading...
-
Product Insights
Gastritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gastritis can be caused by medications such as ibuprofen, aspirin, naproxen on long periods of consumption, excess intake of alcohol, viral infections and trauma. The symptoms of gastritis may include loss of appetite, nausea and vomiting, abdominal pain and black stools. Treatment includes use of...
-
Product Insights
Systemic Mastocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of Systemic Mastocytosis include shortness of breath, low blood pressure, hives and swelling, itching, diarrhea, headache, flushing, and musculoskeletal pain. The Systemic Mastocytosis pipeline market research report provides comprehensive information on the therapeutics under development for Systemic Mastocytosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest...
-
Product Insights
Peritonitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of Peritonitis include cramping, abdominal pain, bloating gas, diarrhea, backache, muscle pains, poor appetite, and constipation. These symptoms can be triggered by food, stress, and hormones. The Peritonitis pipeline market research report provides comprehensive information on the therapeutics under development for Peritonitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.